You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 4, April 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE EIGHTY-SEVENTH ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, COLORADO SPRINGS, COLO, NOV 11-14, 1979
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Management of Polytetrafluoroethylene Graft Occlusions

William H. Baker, MD; M. Margaret Hadcock, MD; Fred N. Littooy, MD

Arch Surg. 1980;115(4):508-513.


Abstract

• Forty-two femoropopliteal-tibial bypass grafts were performed in 37 patients. Autogenous vein was used in 15, a composite polytetrafluoroethylene (PTFE)-vein in 15, and PTFE in 12. Two vein grafts occluded acutely because of veins of inadequate size. Three acute occlusions of PTFE grafts were due to primary thrombosis. Whereas no late vein graft occlusions have occurred, eight of 17 composite and eight of 12 PTFE grafts have subsequently occluded. Satisfactory vein grafts do not commonly occlude unless inadequate inflow or outflow exists. Contrariwise, PTFE grafts have an inherent risk of both early and late thrombosis. Therefore, repeated thrombectomy, may be required to maintain PTFE graft patency. Seventeen thrombectomies or revisions of PTFE or composite grafts in 12 limbs have resulted in seven patent grafts, thus underlining the value of this aggressive surgical approach. Composite grafts offer little advantage over PTFE grafts. The role of anticoagulation has yet to be established.

(Arch Surg 115:508-513, 1980)



Author Affiliations

From the Department of Surgery, Loyola University Medical Center, Maywood, Ill.


Footnotes

Accepted for publication Dec 17, 1979.

Read before the 87th annual meeting of the Western Surgical Association, Colorado Springs, Colo, Nov 13, 1979.

Reprint requests to Department of Surgery, Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153 (Dr Baker).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Femoropopliteal Graft Failures: Clinical Consequences and Success of Secondary Reconstructions
Brewster et al.
Arch Surg 1983;118:1043-1047.
ABSTRACT  

Platelet--Arterial Synthetic Graft Interaction and Its Modification
Callow et al.
Arch Surg 1982;117:1447-1455.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.